Phase III vardenafil data in diabetes patients

Bayer (FSE:BAYG; BAY) and partner GlaxoSmithKline (GSK; LSE:GSK) said 72% of men with diabetes reported improved erections after taking vardenafil compared to 15% taking placebo. The companies said th...